Development and Validation of Stability-Indicating High-Performance Thin-Layer Chromatography for estimation of Ranolazine with Green Analytical Assessment
This study developed and validated a stability-indicating, green high-performance thin-layer chromatographic method for the accurate quantification of ranolazine in pharmaceutical formulations, demonstrating its effectiveness through comprehensive degradation studies and multiple greenness assessment metrics.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Medicines are complex chemical substances that must remain stable and pure from the moment they are manufactured until they reach a patient. To ensure this, scientists rely on analytical chemistry, a field dedicated to identifying and measuring the exact amount of a drug in a sample. A critical part of this process is checking how a drug behaves when it breaks down. Over time, or when exposed to heat, light, or different chemical environments, a drug can degrade into other substances. These breakdown products might be harmless, or they could be harmful, so it is vital for researchers to have a way to separate the original medicine from its degraded parts and measure them accurately. This separation allows manufacturers to confirm that a pill contains the correct dose and that no dangerous impurities have formed during storage.
In a recent study, researchers focused on a heart medication called ranolazine, used to treat chronic chest pain. While the drug is well-known, there was a need for a simpler, faster, and more environmentally friendly way to test it in tablet form. The team developed a new method using a technique called high-performance thin-layer chromatography. Imagine a flat, glass-like plate coated with a fine, sandy material. Scientists place a tiny drop of the drug solution onto this plate and let a liquid solvent travel up the surface. As the liquid moves, it carries the drug with it. Different parts of the drug mixture travel at different speeds, separating into distinct spots. By shining a specific color of light on these spots, researchers can measure exactly how much drug is present and identify any impurities that have formed.
The researchers began by testing various liquid mixtures to find the best one for moving the drug up the plate. They settled on a combination of toluene and methanol, which successfully separated the ranolazine into a clean, compact spot. They determined that the best light to see this spot was a specific shade of ultraviolet, invisible to the human eye but detectable by their instruments. Once the conditions were set, they tested the method's reliability. They applied the drug in amounts ranging from very small to moderately large quantities and found that the results were perfectly consistent, forming a straight line when plotted on a graph. This proved the method could measure the drug accurately whether the sample was tiny or substantial.
To ensure the method was robust, the scientists tested it under slightly different conditions, such as changing the liquid mixture by a tiny fraction or adjusting the light wavelength. The results remained stable, showing that the method would work reliably even if the laboratory environment shifted slightly. They also checked how precise the measurements were by running the same sample multiple times on the same day and on different days. The numbers varied only by a fraction of a percent, confirming that the technique is highly precise. Furthermore, they tested the drug's ability to recover its original form after being mixed with known amounts of the pure substance, finding that the method could accurately detect nearly all of the drug present, with recovery rates hovering around ninety-nine percent.
A significant portion of the study involved forcing the drug to break down to see if the method could spot the resulting fragments. The researchers exposed the drug to strong acids, strong bases, neutral water, heat, and light. In each case, the drug partially degraded, creating new chemical spots on the plate that were clearly separate from the original drug. For instance, when exposed to neutral conditions, the drug broke down significantly, but the method still clearly distinguished the remaining medicine from the new, broken-down pieces. This confirmed that the technique is "stability-indicating," meaning it can tell the difference between the healthy drug and its damaged parts, which is essential for safety testing.
Beyond the chemical results, the team paid close attention to the environmental impact of their work. Traditional testing methods often use large amounts of toxic chemicals that create hazardous waste. The researchers evaluated their new approach using several modern scoring systems designed to measure how "green" or eco-friendly a laboratory procedure is. They found that their method used very small amounts of liquid and generated minimal waste. While the solvents used were still organic and required careful handling, the overall process was far less damaging to the environment than many older techniques. The study concluded that this new approach is not only accurate and fast but also a responsible choice for the future of pharmaceutical testing, offering a way to ensure drug quality without burdening the planet with excessive chemical waste.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.